Compartir
Antibiotics: FDA needs to do more to ensure that drug labels contain up-to-date information: report to congressional committees. (en Inglés)
U. S. Government Accountability Office
(Autor)
·
Createspace Independent Publishing Platform
· Tapa Blanda
Antibiotics: FDA needs to do more to ensure that drug labels contain up-to-date information: report to congressional committees. (en Inglés) - Office, U. S. Government Accountability
32,43 €
36,03 €
Ahorras: 3,60 €
Elige la lista en la que quieres agregar tu producto o crea una nueva lista
✓ Producto agregado correctamente a la lista de deseos.
Ir a Mis Listas
Origen: Estados Unidos
(Costos de importación incluídos en el precio)
Se enviará desde nuestra bodega entre el
Miércoles 31 de Julio y el
Miércoles 14 de Agosto.
Lo recibirás en cualquier lugar de España entre 1 y 5 días hábiles luego del envío.
Reseña del libro "Antibiotics: FDA needs to do more to ensure that drug labels contain up-to-date information: report to congressional committees. (en Inglés)"
"Why GAO Did This Study Antibiotics are critical drugs that have saved millions of lives. Growing bacterial resistance to existing drugs and the fact that few new drugs are in development are public health concerns. The Food and Drug Administration Amendments Act of 2007 (FDAAA) required the Food and Drug Administration (FDA), an agency within the Department of Health and Human Services (HHS), to identify, periodically update, and make publicly available up-to-date breakpoints, the concentrations at which bacteria are categorized as susceptible to an antibiotic. Breakpoints are a required part of an antibiotic's label and are used by providers to determine appropriate treatments. FDAAA provided a financial incentive for antibiotic innovation and required FDA to hold a public meeting on antibiotic incentives and innovation. FDAAA directed GAO to report on the impact of these provisions on new drugs. This report (1) assesses FDA's efforts to help preserve antibiotic effectiveness by ensuring breakpoints on labels are up to date and (2) examines the impact of the antibiotic innovation provisions. GAO examined FDA data, guidance, and other documents; interviewed FDA officials; and obtained information from drug sponsors, such as manufacturers, that market antibiotics. What GAO Recommends GAO recommends that the Commissioner of FDA take steps to help ensure antibiotic labels contain up-to-date information, such as by"
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
Todos los libros de nuestro catálogo son Originales.
El libro está escrito en Inglés.
La encuadernación de esta edición es Tapa Blanda.
✓ Producto agregado correctamente al carro, Ir a Pagar.
